Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acid and barriers. Current research and future developments for peptic ulcer therapy.

J W Rademaker1, R H Hunt

  • 1Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1990
PubMed
Summary

New peptic ulcer treatments focus on enhancing mucosal defense and developing targeted agents. Future therapies aim to inhibit acid secretion and promote wound healing for a potential cure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Influence of Insecticide Resistance, Age, Sex, and Blood Feeding Frequency on Thermal Tolerance of Wild and Laboratory Phenotypes of Anopheles funestus (Diptera: Culicidae).

Journal of medical entomology·2016
Same author

Editorial: towards extended acid suppression--the search continues.

Alimentary pharmacology & therapeutics·2015
Same author

The stomach in health and disease.

Gut·2015
Same author

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need.

Alimentary pharmacology & therapeutics·2014
Same author

Commentary: independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer.

Alimentary pharmacology & therapeutics·2014
Same author

Malaria in South Africa: 110 years of learning to control the disease.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2013

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Peptic ulcer disease (PUD) treatment historically targets acid secretion imbalance.
  • Current therapies like H2 receptor antagonists and proton pump inhibitors (e.g., omeprazole) are effective but have limitations.
  • Understanding mucosal defense mechanisms is crucial for advancing PUD treatment.

Purpose of the Study:

  • To review current and future therapeutic strategies for peptic ulcer disease.
  • To explore novel antisecretory agents targeting specific receptors.
  • To discuss approaches for enhancing mucosal defense and wound healing.

Main Methods:

  • Review of existing medical therapies for peptic ulcer disease.
  • Discussion of emerging drug targets, including muscarinic M3 and gastrin receptors.

Related Experiment Videos

  • Exploration of research into mucosal integrity, immune factors, and growth factors.

    • Main Results:

    • New antisecretory agents are unlikely to surpass current treatments significantly.
    • Targeting muscarinic M3 and gastrin receptors offers alternative acid suppression methods.
    • Enhancing mucosal defense requires understanding vascular, immune, and growth factor roles.

    Conclusions:

    • Future PUD therapies may involve dual-action agents inhibiting acid and promoting healing.
    • Molecular techniques could yield a 'model anti-ulcer' agent for chronic disease cure.
    • Combined approaches targeting both acid suppression and mucosal repair are promising.